Prevention of malnutrition in cystic fibrosis

被引:11
作者
Slae, Mordechai [1 ]
Wilschanski, Michael [1 ]
机构
[1] Hadassah Med Ctr, Dept Pediat Pediat Gastroenterol Hepatol & Nutr, Jerusalem, Israel
关键词
energy intake; improving nutrition; novel therapies; pancreatic insufficiency; AGED; 6-11; YEARS; NUTRITIONAL-STATUS; CHILDREN; IVACAFTOR; PREGNANCY; EFFICACY; SAFETY; ADULTS; F508DEL-CFTR; LUMACAFTOR;
D O I
10.1097/MCP.0000000000000629
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Malnutrition is one of the major burdens of disease in cystic fibrosis. The prevention of malnutrition remains a priority throughout the life of a patient with cystic fibrosis. Literature and guidelines on the management of nutrition in cystic fibrosis have been published; however, here we review updated findings in cystic fibrosis nutrition as well as the role of novel treatments. Recent findings We review the latest studies on the importance and consequences of nutrition in cystic fibrosis. Novel findings on specific nutrients such as vitamin D and sodium can improve our care and thereby health and growth outcomes. The role of exercise has been further studied. In the field of new treatments, we review the role of cystic fibrosis transmembrane-conductance regulator potentiators and modulators in cystic fibrosis nutrition. A new feeding tube fat-digesting device has been developed and shows promise in cystic fibrosis enteral nutrition. Advances in the nutritional care of cystic fibrosis are forming and believed to further develop in the near future, adding to the recent progress in cystic fibrosis patients' health, survival, and quality of life.
引用
收藏
页码:674 / 679
页数:6
相关论文
共 47 条
[11]   Evaluation of salt supplementation in CF infants [J].
Coates, Alison J. ;
Crofton, Patricia M. ;
Marshall, Tom .
JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (06) :382-385
[12]   Malnutrition in Cystic Fibrosis: A Review [J].
Culhane, Suzanne ;
George, Carolyn ;
Pearo, Brittany ;
Spoede, Elizabeth .
NUTRITION IN CLINICAL PRACTICE, 2013, 28 (06) :676-683
[13]   Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study [J].
Davies, Jane C. ;
Cunningham, Steve ;
Harris, William T. ;
Lapey, Allen ;
Regelmann, Warren E. ;
Sawicki, Gregory S. ;
Southern, Kevin W. ;
Robertson, Sarah ;
Green, Yulia ;
Cooke, Jon ;
Rosenfeld, Margaret .
LANCET RESPIRATORY MEDICINE, 2016, 4 (02) :107-115
[14]   Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation [J].
Davies, Jane C. ;
Wainwright, Claire E. ;
Canny, Gerard J. ;
Chilvers, Mark A. ;
Howenstine, Michelle S. ;
Munck, Anne ;
Mainz, Jochen G. ;
Rodriguez, Sally ;
Li, Haihong ;
Yen, Karl ;
Ordonez, Claudia L. ;
Ahrens, Richard .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (11) :1219-1225
[15]  
de Neri LC, 2019, J PEDIAT GASTROENTER, V68, P394
[16]   Guidelines for the management of pregnancy in women with cystic fibrosis [J].
Edenborough, F. P. ;
Borgo, G. ;
Knoop, C. ;
Lannefors, L. ;
Mackenzie, W. E. ;
Madge, S. ;
Morton, A. M. ;
Oxley, H. C. ;
Touw, D. J. ;
Benham, M. ;
Johannesson, M. .
JOURNAL OF CYSTIC FIBROSIS, 2008, 7 :S2-S32
[17]   Nutritional benefits of neonatal screening for cystic fibrosis [J].
Farrell, PM ;
Kosorok, MR ;
Laxova, A ;
Shen, GH ;
Koscik, RE ;
Bruns, WT ;
Splaingard, M ;
Mischler, EH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :963-969
[18]  
Freedman S, 2017, J PEDIATR GASTR NUTR, V65, P97, DOI [10.1097/MPG.0000000000001617, 10.1097/mpg.0000000000001617]
[19]   Pregnancy and cystic fibrosis: Approach to contemporary management [J].
Geake, James ;
Tay, George ;
Callaway, Leonie ;
Bell, Scott C. .
OBSTETRIC MEDICINE, 2014, 7 (04) :147-155
[20]   A case-control study on pregnancy in Italian Cystic Fibrosis women. Data from the Italian Registry [J].
Giordani, B. ;
Quattrucci, S. ;
Amato, A. ;
Salvatore, M. ;
Padoan, R. .
RESPIRATORY MEDICINE, 2018, 145 :200-205